1-5 of 5
Salem Salem Alshemmari
Close
Sort by
Journal Articles

Molecular Aberrations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome with Excess Blast II (MDS-EB II) in Kuwait

Ahmad Alhuraiji, Mohan Ram, Fatima M Khadadah, Anita Kunhikrishnan, Abdul Rashid Shah, Abdulaziz Hamadah, Salem Salem Alshemmari, Shakir Bahzad, Ramesh Pandita
Journal: Blood
Blood (2022) 140 (Supplement 1): 11795.
https://doi.org/10.1182/blood-2022-167898
Published: 2022
Journal Articles

Chronic Lymphocytic Leukemia Treatment: Single Center Experience

Salem Salem Alshemmari, Ahmed Al-sarraf, Anita Kunhikrishnan, Ahmad Alhuraiji, Abdulaziz Hamadah
Journal: Blood
Blood (2022) 140 (Supplement 1): 12416–12417.
https://doi.org/10.1182/blood-2022-168442
Published: 2022
Journal Articles

Prediction of IGHV Mutational Status Among Patients with Chronic Lymphocytic Leukemia

Salem Salem Alshemmari, Faisal Almunefi, Anita Kunhikrishnan, Abdulaziz Hamadah
Journal: Blood
Blood (2022) 140 (Supplement 1): 12379.
https://doi.org/10.1182/blood-2022-171002
Published: 2022
Journal Articles

Predicting Stage Progression in Binet Stage a Chronic Lymphocytic Leukemia

Salem Salem Alshemmari, Mazyad Jamal Almazyad, Anita Kunhikrishnan, Salah Al-Humood
Journal: Blood
Blood (2022) 140 (Supplement 1): 12380–12381.
https://doi.org/10.1182/blood-2022-163014
Published: 2022
Journal Articles

Treatment Free Remission (TFR) in Chronic Myeloid Leukemia-Chronic Phase (CML-CP), Kuwait Experience

Ahmad Alhuraiji, Mahmoud Hasaneen, Salem Salem Alshemmari, Abdulaziz Hamadah, Ramesh Pandita, Fatima M Khadadah, Mona Hassanein
Journal: Blood
Blood (2022) 140 (Supplement 1): 12235.
https://doi.org/10.1182/blood-2022-164783
Published: 2022